Nate Crossett

Stock Analyst at Exane BNP Paribas

(2.39)
# 1,423
Out of 4,667 analysts
37
Total ratings
50%
Success rate
0.09%
Average return

Stocks Rated by Nate Crossett

Medical Properties Trust
Jul 2, 2024
Downgrades: Neutral
Price Target: $6$4
Current: $4.22
Upside: -5.10%
Omega Healthcare Investors
Feb 8, 2024
Upgrades: Neutral
Price Target: $30
Current: $39.90
Upside: -24.81%
Agree Realty
Dec 13, 2023
Downgrades: Neutral
Price Target: $64
Current: $77.35
Upside: -17.26%
NETSTREIT
Dec 13, 2023
Downgrades: Neutral
Price Target: $17
Current: $15.94
Upside: +6.65%
Realty Income
Dec 13, 2023
Upgrades: Outperform
Price Target: $63
Current: $57.12
Upside: +10.29%
Alexandria Real Estate Equities
Oct 11, 2023
Initiates: Neutral
Price Target: $108
Current: $104.13
Upside: +3.72%
Ventas
Oct 11, 2023
Initiates: Outperform
Price Target: n/a
Current: $64.28
Upside: -
Digital Realty Trust
Jul 28, 2023
Upgrades: Outperform
Price Target: $138
Current: $184.43
Upside: -25.17%
Prologis
Jul 20, 2023
Upgrades: Outperform
Price Target: $141
Current: $114.14
Upside: +23.54%
Gaming and Leisure Properties
Jun 14, 2023
Initiates: Outperform
Price Target: $63
Current: $50.55
Upside: +24.63%
Initiates: Underperform
Price Target: $42
Current: $43.69
Upside: -3.87%
Initiates: Outperform
Price Target: $41
Current: $32.16
Upside: +27.51%
Initiates: Outperform
Price Target: $29
Current: $33.69
Upside: -13.91%
Initiates: Underperform
Price Target: $74
Current: $56.47
Upside: +31.05%
Initiates: Outperform
Price Target: n/a
Current: $20.45
Upside: -
Initiates: Underperform
Price Target: $9.6
Current: $7.24
Upside: +32.69%
Initiates: Outperform
Price Target: $66
Current: $115.77
Upside: -42.99%
Initiates: Outperform
Price Target: $38
Current: $22.36
Upside: +69.98%
Initiates: Outperform
Price Target: $886
Current: $919.62
Upside: -3.66%
Downgrades: Hold
Price Target: $31$30
Current: $28.73
Upside: +4.42%
Initiates: Buy
Price Target: $21
Current: $3.28
Upside: +540.24%
Downgrades: Hold
Price Target: $21$25
Current: $11.82
Upside: +111.60%
Upgrades: Buy
Price Target: n/a
Current: $18.39
Upside: -